This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Rorer Biotechnology Inc.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Michael Jaye - Innovator in Recombinant DNA Technology
Introduction
Michael Jaye is a notable inventor based in Arlington, VA, who has made significant contributions to the field of biotechnology. His work primarily focuses on recombinant DNA technology, which has important implications for medical applications.
Latest Patents
Michael Jaye holds a patent for a recombinant DNA vector encoding human endothelial cell growth factor. This invention involves the application of recombinant DNA technology to create cloning vehicles that encode the endothelial cell growth factor (ECGF) protein. The procedures outlined in the patent allow for the recovery of ECGF protein that is essentially free of other human-origin proteins. This product is particularly useful for diagnostic applications and has potential in treating damaged blood vessels and other endothelial cell-line structures.
Career Highlights
Throughout his career, Michael Jaye has been associated with Rorer Biotechnology Inc., where he has contributed to various innovative projects. His expertise in recombinant DNA technology has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Michael has worked alongside notable colleagues such as Wilson Burgess and Thomas Maciag, contributing to advancements in their field through collaborative efforts.
Conclusion
Michael Jaye's work in recombinant DNA technology exemplifies the impact of innovation in biotechnology. His contributions continue to pave the way for advancements in medical treatments and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile